Manipal Hospitals, Google Cloud Partner to Boost AI in Indian Healthcare

Manipal Hospitals and Google Cloud collaborate to bring in a new era of digital healthcare driven by AI. Through the relationship, the hospital will use Google Cloud's secure cloud infrastructure, advanced data analytics, and artificial intelligence

Online registration system for medical devices upgraded by CDSCO

The CDSCO has recently upgraded its online registration system and required all manufacturers of medical devices to re-submit their market standing...

MicroPort Orthopedics Launches Medial-Pivot Orthopedic Implants in India

MicroPort Orthopedics, a global medical device company located in the United States, has introduced in India the Evolution Medial-Pivot Knee, its second-generation...

Zydus Gets USFDA Approval for Duchenne Muscular Dystrophy Drug

The United States Food and Drug Administration (USFDA) has given Zydus Lifesciences final approval to produce medications called Jaythari (Deflazacort).

Government Mandates CEA Registration for Diagnostic Labs

In a strategic approach to regulating the rapidly growing diagnostic sector, the state health department has made it mandated registration of all diagnostic labs under the Clinical Establishment Act (CEA) 2010. Despite repeated notifications at both

Cipla, Sun Pharma, Ipca Labs, JB Pharma boost Indian pharma growth in March

The Indian Pharma Market (IPM) created a conducive growth environment in 2025 for March at 9.3% YoY, which shows a remarkable recovery from the months gone by. Key growth drivers included Cipla...

Glenmark, Sun Pharma, Zydus recall medicines in US over manufacturing issues

According to recent information collected from the U.S. Food and Drug Administration (FDA), major leading pharmaceutical firms in India are recalling...

CRISPR technology identifies crucial genes linked to Parkinson's disease

Researchers in the US have utilized advanced CRISPR interference technology to discover a new collection of genes that enhance the likelihood of developing Parkinson's disease...

3RD Annual Pharma Impurities Conclave 2025

With the increasing scrutiny on drug safety and efficacy, understanding impurities is more important than ever and ever evolving guidelines are not aiding the efforts. To address those lacunas, Eminence has come up with 3rd Annual Pharma Impurity Con

Announcing the 4th Edition Drug Safety Symposium 2025

With patient safety becoming more critical than ever in today's evolving healthcare landscape, the demand for robust drug safety practices continues to surge. After several successful editions in India and Dubai, Eminence Group returns with 4th Editi

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.